AstraZeneca

AstraZeneca's Evusheld nabs its first global nod as a COVID treatment
Fierce Pharma
Wed, 08/31/22 - 10:34 pm
AstraZeneca
Evusheld
COVID-19
Japan
AstraZeneca’s Farxiga reduces CV mortality risk in Phase III trials
Clinical Trials Arena
Mon, 08/29/22 - 11:01 am
AstraZeneca
Farxiga
clinical trials
heart failure
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
artificial intelligence
Pfizer
Novartis
AstraZeneca
Johnson & Johnson
Bristol Myers Squibb
Takeda
GSK
Bayer
Astellas
AstraZeneca may not stay in vaccines, but CEO has no COVID regrets
Reuters
Tue, 08/23/22 - 10:32 pm
AstraZeneca
vaccines
Pharma CEOs
Pascal Soriot
Genprex to progress Phase I/II trial of non-small cell lung cancer therapy
Clinical Trials Arena
Tue, 08/16/22 - 12:15 pm
Genprex
clinical trials
Reqorsa
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca heads to court to contest former exec's move to crosstown rival GSK: report
Fierce Pharma
Tue, 08/16/22 - 10:54 am
AstraZeneca
GSK
executives
With Pfizer, AZ and Merck leading the way, Big Pharma weathered the economic storm in Q2
Fierce Pharma
Mon, 08/15/22 - 10:35 am
earnings
Pfizer
AstraZeneca
Merck
Big Pharma
inflation
supply chain
Ukraine
pandemic
COVID-19
AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug
Endpoints
Mon, 08/8/22 - 09:54 am
AstraZeneca
Hutchmed
clinical trials
Tagrisso
savolitinib
lung cancer
FDA approves AstraZeneca, Daiichi drug in breast cancer first
BioPharma Dive
Sun, 08/7/22 - 11:24 pm
AstraZeneca
Daiichi Sankyo
breast cancer
Enhertu
FDA
HER2-low breast cancer
Lilly, AZ, AbbVie and J&J face big potential hit from Medicare pricing bill: analysts
Fierce Pharma
Mon, 08/1/22 - 10:53 am
Eli Lilly
AstraZeneca
JNJ
AbbVie
legislation
drug pricing
Medicare
Fresh disappointment for Innate’s Astra lifeline
EP Vantage
Mon, 08/1/22 - 10:41 am
Innate Pharma
AstraZeneca
Lumoxiti
clinical trials
monalizumab
AstraZeneca axes Moderna-partnered, phase 2 heart disease drug plus a Wee inhibitor
Fierce Biotech
Fri, 07/29/22 - 10:12 am
AstraZeneca
Moderna Therapeutics
heart disease
MRNA
Wee1 inhibitors
AstraZeneca wins two recommendations, one priority review
Morningstar
Mon, 07/25/22 - 10:54 am
AstraZeneca
Europe
Daiichi Sankyo
Enhertu
breast cancer
Ultomiris
Tezspire
Study shows AstraZeneca's Covid-19 mAb Evusheld may not work against dominant Omicron strain
Endpoints
Thu, 07/21/22 - 10:39 am
AstraZeneca
COVID-19
Evusheld
Omicron variant
AstraZeneca, Pfizer, Novartis and more lose out in China's latest round of drug price cuts
Fierce Pharma
Wed, 07/13/22 - 10:03 am
China
drug pricing
price cuts
AstraZeneca
Pfizer
Novartis
generics
AstraZeneca, GSK and more weathered Q2's economic headwinds, but Roche's stock took a hit: analysts
Fierce Pharma
Wed, 07/6/22 - 11:41 pm
AstraZeneca
GSK
Roche
Biopharma Investment in China is Thriving Amid U.S. Downturn
BioSpace
Tue, 07/5/22 - 11:52 pm
China
biotech
WuXi Biologics
Boehringer Ingelheim
Siemens Healthineers
AstraZeneca
AstraZeneca agrees $1.3bn deal to buy oncology player TeneoTwo
Pharmaforum
Tue, 07/5/22 - 11:57 am
AstraZeneca
TeneoTwo
M&A
hematologic cancers
Oxford Biomedica signs up for 3 more years of making AstraZeneca COVID shots⁠—on an 'as needed basis'
Fierce Pharma
Fri, 07/1/22 - 10:29 am
COVID-19
AstraZeneca
Oxford BioMedica
vaccines
AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer
BioPharma Dive
Thu, 06/30/22 - 11:01 am
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer

Pages